FDA Adverse Event Injury Summary report: N

BERLIN HEART EXCOR PEDIATRIC VAD

MDR report key: 7914100 · Received September 27, 2018

Report

Report Number
3004582654-2018-00048
Event Type
Injury
Date Received
September 27, 2018
Date of Event
September 10, 2018
Report Date
September 27, 2018
Manufacturer
BERLIN HEART GMBH
Product Code
DSQ
PMA / PMN Number
P160035
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
DC, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER: E2013009. BERLIN HEART INC. (IMPORTER NUMBER: (B)(4)) IS SUBMITTING THE REPORT ON BEHALF OF BERLIN HEART GMBH(MANUFACTURER). A FOLLOW UP ON THE PATIENT CONFIRMED A VON WILEBRAND DEFICIENCY. G8: ADVERSE EVENT TERM: ISCHEMIC CVA.

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER: E2013009. BERLIN HEART INC. (IMPORTER NUMBER: (B)(4)) IS SUBMITTING THE REPORT ON BEHALF OF BERLIN HEART GMBH(MANUFACTURER). A CORRECTION TO THE H1, THE TYPE OF REPORTABLE EVENT IS SERIOUS INJURY, NOT MALFUNCTION.

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER: E2013009. BERLIN HEART INC. (IMPORTER NUMBER: (B)(4)) IS SUBMITTING THE REPORT ON BEHALF OF BERLIN HEART GMBH(MANUFACTURER). CORRECTION TO THE B5. DESCRIBE THE EVENT OR PROBLEM: THE SITE CONTACTED BERLIN HEART INC. ON SEPTEMBER 11, 2018, NOT SEPTEMBER 10, 2018.

Description of Event or Problem · 0

ON (B)(6) 2018, THE SITE CONTACTED BERLIN HEART INC. TO REPORT A PATIENT SUPPORTED IN BVAD CONFIGURATION OF THE EXCOR BLOOD PUMP HAD AN ISCHEMIC CVA. PATIENT HAD A PUMP CHANGE ON THE LVAD PUMP IN BVAD CONFIGURATION ON (B)(6) 2018 DUE TO THROMBUS IN THE PUMP. DURING PHYSICAL THERAPY ON (B)(6) 2018, DECREASED MOBILITY WAS NOTED ON THE PATIENTS LEFT SIDE. AN RVAD PUMP CHANGE OCCURRED ON (B)(6) 2018 DUE TO THROMBUS IN THE OUTFLOW VALVE. ANTICOAGULATION WAS FOUND TO BE BELOW TARGET RANGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
755924 BERLIN HEART EXCOR PEDIATRIC VAD VENTRICULAR ASSIST DEVICE DSQ BERLIN HEART GMBH

Patients

Seq Age Sex Outcome Treatment
1 18 MO Other